Association of KCNJ11 (E23K) gene polymorphism with susceptibility to type 2 diabetes in Iranian patients

Authors
Ali Rastegari 1
Mohammad Rabbani 1
Hamid Mirmohammad Sadeghi 1
Elham Faghih Imani 2
Akbar Hasanzadeh 3
Fatemeh Moazen 1
1 Department of Pharmaceutical Biotechnology, University of Medical Sciences, Isfahan, Iran
2 Department of Internal Medicine, University of Medical Sciences, Isfahan, Iran
3 Department of Biostatistics and Epidemiology, University of Medical Sciences, Isfahan, Iran
Abstract
Background: Type 2 diabetes (T2D) is a multifactorial disease with susceptibility of several genes that are related to T2D. Insulin secretion pathway starts with potassium channels in pancreatic beta cells. KCNJ11 gene encodes ATP-sensitive potassium channel subunits. Some studies suggested that KCNJ11 (E23K) mutation increases the risk of T2D. Therefore, present study was designed to investigate the association between E23K polymorphism of KCNJ11 gene and type 2 diabetes mellitus (T2DM) in the Iranian population.
Materials and Methods: The type of study was case-control and 40 unrelated subjects, including 20 healthy controls and 20 diabetic patients were recruited (diagnosed based on American Diabetes Association criteria). Blood samples were used for isolation of genomic deoxyribonucleic acid (DNA). Having extracted the genomic DNA from human blood leukocytes by means of High Pure PCR Template Preparation Kit, PCR-restriction fragment length polymorphism method was used to detect KCNJ11 E23K gene polymorphism. BanII restriction enzyme was used for digestion. Data were analyzed using Chi-square or Fisher exact test or independent t-test, as appropriate. P < 0.05 was considered.
Results: We found that the carrier homozygous for KK genotype are susceptible to T2D (0.049) and in patients the frequency of K allele was higher than control subjects (0.048).
Conclusion: The present study suggests that KCNJ11 (E23K) gene polymorphism is associated with T2DM.

Keywords

1.
Prokopenko I, McCarthy MI, Lindgren CM. Type 2 diabetes: New genes, new understanding. Trends Genet 2008;24:613-21.  Back to cited text no. 1
    
2.
Distefano JK, Watanabe RM. Pharmacogenetics of anti-diabetes drugs. Pharmaceuticals (Basel) 2010;3:2610-46.  Back to cited text no. 2
    
3.
Dean L, McEntyre J. The genetic landscape of diabetes (electronic resource). CH. 3. Bethesda, Md: NCBI : NIDDK, 2004. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1667/. [Last accessed on 2013 May 27].  Back to cited text no. 3
    
4.
Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995;268:426-9.  Back to cited text no. 4
    
5.
Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003;52:568-72.  Back to cited text no. 5
    
6.
Samadikuchaksaraei A, Ramandi MF, Khatami S, Hashemi MJ, Haqparast S, Fard-Esfahani P. E23K polymorphism in Iranian patients with coronary heart disease. ARYA Atheroscler 2010;5:55-60.  Back to cited text no. 6
    
7.
He YY, Zhang R, Shao XY, Hu C, Wang CR, Lu JX, et al. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients. Acta Pharmacol Sin 2008;29:983-9.  Back to cited text no. 7
    
8.
Shaat N, Ekelund M, Lernmark A, Ivarsson S, Almgren P, Berntorp K, et al. Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus. Diabetologia 2005;48:2544-51.  Back to cited text no. 8
    
9.
Schwanstecher C, Meyer U, Schwanstecher M. K (IR) 6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels. Diabetes 2002;51:875-9.  Back to cited text no. 9
    
10.
Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF, et al. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes 2007;56:531-6.  Back to cited text no. 10
    
11.
Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G, et al. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+channel gene (KIR6.2/BIR): A meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 1998;41:1511-5.  Back to cited text no. 11
    
12.
Chistiakov DA, Potapov VA, Khodirev DS, Shamkhalova MS, Shestakova MV, Nosikov VV. The KCNJ11 E23K and ABCC8 exon 31 variants contribute to susceptibility to type 2 diabetes, glucose intolerance and altered insulin secretion in a Russian population. Diabetes Metab Syndr Clin Res Rev 2008;2:185-91.  Back to cited text no. 12
    
13.
Sesti G, Laratta E, Cardellini M, Andreozzi F, Del Guerra S, Irace C, et al. The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'- triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. J Clin Endocrinol Metab 2006;91:2334-9.  Back to cited text no. 13
    
14.
Alsmadi O, Al-Rubeaan K, Wakil SM, Imtiaz F, Mohamed G, Al-Saud H, et al. Genetic study of Saudi diabetes (GSSD): Significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Diabetes Metab Res Rev 2008;24:137-40.  Back to cited text no. 14
    
15.
Ragia G, Tavridou A, Petridis I, Manolopoulos VG. Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated type 2 diabetic patients. Diabetes Res Clin Pract 2012;98:119-24.  Back to cited text no. 15
    
16.
DeFronzo RA, Devjit T, Dawn CS, MaryAnn B, George AB, Thomas AB, et al. Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk. Diabetes Care 2013;36:3607-12.  Back to cited text no. 16
    
17.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.  Back to cited text no. 17
    
18.
Li YY. The KCNJ11 E23K gene polymorphism and type 2 diabetes mellitus in the Chinese Han population: A meta-analysis of 6,109 subjects. Mol Biol Rep 2013;40:141-6.  Back to cited text no. 18
    
19.
Asaf A, Ayesh BM, Hamdona OM. Single nucleotide polymorphism E23K of KCNJ11 gene and other risk factors associated with type-2 diabetes mellitus in Gaza. Int J Chem Life Sci 2013;2:1146-52.  Back to cited text no. 19
    
20.
Wang GF, Jiang WJ, Jiang XB, Wu YL, Zhang DF. Correlation study of KCNJ11 gene E23K polymorphism with type 2 diabetes mellitus. Acta Acad Med 2011;2:4-8.  Back to cited text no. 20
    
21.
Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC, et al. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabet Med 2001;18:206-12.  Back to cited text no. 21
    
22.
Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. 18 th ed. Ch. 344. New York: McGraw-Hill Professional; 2011.  Back to cited text no. 22
    
23.
Riedel MJ, Boora P, Steckley D, de Vries G, Light PE. Kir6.2 polymorphisms sensitize beta-cell ATP-sensitive potassium channels to activation by acyl CoAs: A possible cellular mechanism for increased susceptibility to type 2 diabetes? Diabetes 2003;52:2630-5.  Back to cited text no. 23
Advanced Biomedical Research
Volume 2015, January
January 2015
Pages 1-5